Scarica l'app Stockscreener
4.95
1.20%
-0.06
Dopo l'orario di chiusura:
5.04
0.09
+1.82%
Precedente Chiudi:
$5.01
Aprire:
$5.01
Volume 24 ore:
420.77K
Relative Volume:
0.41
Capitalizzazione di mercato:
$296.48M
Reddito:
-
Utile/perdita netta:
$-44.80M
Rapporto P/E:
-6.60
EPS:
-0.75
Flusso di cassa netto:
$-30.67M
1 W Prestazione:
-1.20%
1M Prestazione:
-14.21%
6M Prestazione:
-25.90%
1 anno Prestazione:
-8.33%
Intervallo 1D:
$4.86
$5.01
Intervallo di 1 settimana:
$4.78
$5.26
Portata 52W:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Nome
Aldeyra Therapeutics Inc
Settore
Industria
Telefono
781-761-4904
Indirizzo
131 HARTWELL AVENUE, LEXINGTON, MA
Confronta ALDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
4.95 | 300.83M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-03 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Ripresa | H.C. Wainwright | Buy |
| 2022-04-27 | Ripresa | H.C. Wainwright | Buy |
| 2021-02-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-10-30 | Iniziato | Jefferies | Buy |
| 2020-10-16 | Iniziato | BTIG Research | Buy |
| 2020-09-22 | Iniziato | Alliance Global Partners | Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Outperform |
| 2018-12-04 | Iniziato | Citigroup | Buy |
| 2018-09-26 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Iniziato | Janney | Buy |
| 2018-01-26 | Iniziato | Seaport Global Securities | Buy |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2016-07-01 | Iniziato | Stifel | Buy |
| 2015-07-01 | Iniziato | Canaccord Genuity | Buy |
| 2015-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2015-03-20 | Reiterato | H.C. Wainwright | Buy |
| 2014-11-18 | Iniziato | H.C. Wainwright | Buy |
| 2014-06-19 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie
After Two Regulatory Setbacks For Reproxalap, Can Aldeyra's Persistence Pay Off? - RTTNews
Institution Moves: Should I hold or sell Aldeyra Therapeutics Inc nowJuly 2025 Analyst Calls & Consistent Profit Trade Alerts - khodrobank.com
Surprises Report: Is Aldeyra Therapeutics Inc stock trending bullishCPI Data & Low Risk High Win Rate Picks - خودرو بانک
Aldeyra: 2 CRLs And A Precedent Gap Ahead Of Repro's PDUFA Merit Caution (Rating Downgrade) - Seeking Alpha
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Crosses Below 50 Day Moving AverageHere's What Happened - MarketBeat
Aug Sectors: Is NTRA benefiting from innovation trendsForecast Cut & High Conviction Buy Zone Alerts - خودرو بانک
Gains Recap: Should I hold or sell Aldeyra Therapeutics Inc. nowWeekly Trade Report & Expert Verified Stock Movement Alerts - خودرو بانک
Dividend Watch: Is Aldeyra Therapeutics Inc. part of any ETFPortfolio Return Summary & AI Powered Buy and Sell Recommendations - خودرو بانک
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap - Quantisnow
Proliferative vitreoretinopathy Pipeline Analysis & Clinical Trials, 2025, DelveInsight | Aldeyra Therapeutics, Tetra Bio-Pharma, Aviceda Therapeutics - The Globe and Mail
Published on: 2025-09-08 19:00:28 - beatles.ru
Is Aldeyra Therapeutics Inc. benefiting from interest rate changesWeekly Profit Analysis & Short-Term High Return Ideas - beatles.ru
683 Capital Management LLC Acquires 186,000 Shares of Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Advanced analytics toolkit walkthrough for Aldeyra Therapeutics Inc.Market Activity Report & Low Risk Growth Stock Ideas - Newser
How to integrate Aldeyra Therapeutics Inc. into portfolio analysis toolsWeekly Loss Report & Community Driven Trade Alerts - Newser
Is Aldeyra Therapeutics Inc. a candidate for recovery play2025 Analyst Calls & Weekly Top Gainers Alerts - Newser
Earnings Recap: What is the long term forecast for Aldeyra Therapeutics Inc. stock2025 Risk Factors & Daily Volume Surge Signals - خودرو بانک
Wellington Management Group LLP Invests $675,000 in Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Momentum divergence signals in Aldeyra Therapeutics Inc. chartQuarterly Profit Report & Weekly High Conviction Ideas - Newser
Will Aldeyra Therapeutics Inc. outperform the marketJuly 2025 EndofMonth & Real-Time Volume Triggers - Newser
Does Aldeyra Therapeutics Inc. have strong fundamentalsCPI Data & AI Based Buy and Sell Signals - خودرو بانک
News impact scoring models applied to Aldeyra Therapeutics Inc.2025 Earnings Impact & Daily Market Momentum Tracking - Newser
Aldeyra Therapeutics (ALDX) Stock Price, News & Analysis - MarketBeat
Sector ETF performance correlation with Aldeyra Therapeutics Inc.Market Risk Analysis & Consistent Profit Trading Strategies - Newser
Historical volatility pattern of Aldeyra Therapeutics Inc. visualizedQuarterly Market Review & High Return Trade Opportunity Guides - Newser
What technical models suggest about Aldeyra Therapeutics Inc.’s comebackWeekly Profit Report & Daily Chart Pattern Signals - Newser
Best data tools to analyze Aldeyra Therapeutics Inc. stock2025 Analyst Calls & Low Risk High Reward Ideas - Newser
How moving averages guide Aldeyra Therapeutics Inc. tradingRisk Management & Precise Buy Zone Tips - Newser
Is Aldeyra Therapeutics Inc. building a consolidation baseMarket Performance Report & AI Based Trade Execution Alerts - Newser
Can trapped investors hope for a rebound in Aldeyra Therapeutics Inc.Oil Prices & High Yield Stock Recommendations - Newser
Aldeyra granted fast track designation for ADX-2191 by FDA - MSN
Market reaction to Aldeyra Therapeutics Inc.’s recent newsMarket Movement Recap & AI Based Buy and Sell Signals - Newser
Can Aldeyra Therapeutics Inc. deliver consistent dividendsJuly 2025 Momentum & AI Based Buy and Sell Signals - خودرو بانک
Comparing Aldeyra Therapeutics Inc. in custom built stock radars2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Using economic indicators to assess Aldeyra Therapeutics Inc. potentialWeekly Trade Recap & Reliable Breakout Stock Forecasts - Newser
Is Aldeyra Therapeutics Inc. stock bottoming outAnalyst Downgrade & Expert Curated Trade Ideas - Newser
Invesco Ltd. Purchases 471,231 Shares of Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Full technical analysis of Aldeyra Therapeutics Inc. stockBear Alert & Detailed Earnings Play Strategies - Newser
Aldeyra Therapeutics Inc. stock trendline breakdownEarnings Miss & High Conviction Buy Zone Alerts - Newser
Can Aldeyra Therapeutics Inc. generate free cash flowInsider Buying & Community Verified Trade Signals - خودرو بانک
Using fundamentals and technicals on Aldeyra Therapeutics Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Aldeyra Therapeutics: A High-Potential Biotech Play in Immune-Mediated and Ophthalmic Diseases - AInvest
Tech Rally: Is Aldeyra Therapeutics Inc. stock forming a cup and handleTrade Risk Summary & High Return Stock Watch Alerts - خودرو بانک
Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
Real time scanner hits for Aldeyra Therapeutics Inc. explainedBreakout Watch & Daily Stock Trend Watchlist - Newser
Ranking Aldeyra Therapeutics Inc. among high performing stocks via tools2025 Price Momentum & Risk Managed Trade Strategies - Newser
Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):